Retina/Vitreous News

In this Healio Video Perspective from the ASRS meeting, Michael A. Singer, MD, of the University of Texas Health Science Center in San Antonio, discusses topline results for MCO-010 for the treatment of retinitis pigmentosa.

While the prevalence of blindness due to age-related macular degeneration decreased globally from 2000 to 2020, researchers warn that the social and economic impact of AMD may grow as the population ages.

In this video, Rishi P. Singh, MD, discusses results from part 1 of the phase 2/3 SIGLEC trial assessing AVD-104 for geographic atrophy, presented at the ASRS annual meeting in Stockholm.

In this edition, sozinibercept combination therapy shows durability, comparable improvements with aflibercept and more.

Ocular Therapeutix obtained FDA support to use the phase 3 SOL-R trial as the next step in the regulatory process for Axpaxli, according to a press release.

Nearly 2 years after it voluntarily recalled Susvimo, Genentech recently announced plans to reintroduce the implant.

In this Healio Video Perspective from the ASRS meeting, Dilsher Dhoot, MD, of California Retina Consultants discusses interim safety and efficacy results for OTX-TKI for the treatment of nonproliferative diabetic retinopathy.

Physicians who utilized remote scribes saw an increase in patient satisfaction compared with those who used in-person scribes, according to a study presented at the American Society of Retina Specialists meeting.

Practices should have a plan for disasters and conduct drills to be prepared, according to a speaker at the American Society of Retina Specialists annual meeting.

Intravitreal injections have a large environmental impact, estimated to be around 210 million kg of CO2 equivalent per year in the U.S. alone, according to a presenter at the American Society of Retina Specialists annual meeting.